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Abstract
Elucidating the in vitro differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells is important
for understanding both normal and pathological hematopoietic development in vivo. For this purpose, a robust and simple
hematopoietic differentiation system that can faithfully trace in vivo hematopoiesis is necessary. In this study, we
established a novel serum-free monolayer culture that can trace the in vivo hematopoietic pathway from ES/iPS cells to
functional definitive blood cells via mesodermal progenitors. Stepwise tuning of exogenous cytokine cocktails induced the
hematopoietic mesodermal progenitors via primitive streak cells. These progenitors were then differentiated into various
cell lineages depending on the hematopoietic cytokines present. Moreover, single cell deposition assay revealed that
common bipotential hemoangiogenic progenitors were induced in our culture. Our system provides a new, robust, and
simple method for investigating the mechanisms of mesodermal and hematopoietic differentiation.
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Introduction
Because of pluripotency and self-renewal, human embryonic
stem (ES) cells and induced pluripotent stem (iPS) cells are
potential cell sources for regenerative medicine and other clinical
applications, such as cell therapies, drug screening, toxicology, and
investigation of disease mechanisms [1,2,3]. iPS cells are
reprogrammed somatic cells with ES cell-like characteristics that
are generated by introducing certain combinations of genes,
proteins, or small molecules into the original cells [4,5,6,7].
Patient-derived iPS cells have facilitated individualized regenera-
tive medicine without immunological or ethical concerns.
Moreover, patient- or disease-specific iPS cells are an important
resource for unraveling human hematological disorders. However,
for this purpose, a robust and simple hematopoietic differentiation
system that can reliably mimic in vivo hematopoiesis is necessary.
Mesodermal and hematopoietic differentiation is a dynamic
event associated with changes in both the location and phenotype of
cells[8,9,10,11].Some primitive streak(PS)cellsappearingjustafter
gastrulation form the mesoderm, and a subset of mesodermal cells
differentiate into hematopoietic cell lineages [9,12,13,14,15,16].
Previous studies have accumulated evidence on these embryonic
developmental pathways.
The leading methods of blood cell induction from ES/iPS
cells employ 2 different systems: monolayer animal-derived
stromal cell coculture and 3-dimensional embryoid body (EB)
formation. Both methods can produce hematopoietic cells from
mesodermal progenitors, and combinations of cytokines can
control, to some extent, the specific lineage commitment
[1,2,17,18,19,20,21,22,23,24,25,26,27,28]. In the former meth-
od, a previous study showed that OP9 stromal cells, which are
derived from the bone marrow of osteopetrotic mice, augment the
survival of human ES cell-derived hematopoietic progenitors [29].
However, as the stromal cell condition controls the robustnessof the
system, it can be relatively unstable. Furthermore, the induction of
hematopoietic cells from human pluripotent cells on murine-
derived cells is less efficient than that from mice cells.
In EB-based methods, hematopoietic cells emerge from specific
areas positive for endothelial markers such as CD31 [30,31,32].
Through these methods, previous studies have generated a list of
landmark genes for each developmental stage, such as T and
KDR genes for the PS and mesodermal cells, respectively
[12,16,17,18,25,28,33,34,35,36], and also have emphasized ap-
propriate developmental conditions consisting of specific micro-
environments, signal gradients, and cytokines given in suitable
combinations with appropriate timing. For robust and reproduc-
ible specification to myelomonocytic lineages of cells, some recent
studies have converted to serum-independent culture by using EB
formation [37]. However, the difficulty in applying 3-dimensional
location information inside EBs prevents substantial increases in
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structure of the EB complicates tracking and determination of
hematopoietic–stromal cell interactions.
To overcome these issues, we established a novel serum-free
monolayer hematopoietic cell differentiation system from human
ES and iPS cells. Although there are no reports describing the shift
of human ES/iPS cells from primitive to definitive erythropoiesis
in a monolayer xeno-cell-free condition, our system can trace the
in vitro differentiation of human ES/iPS cells into multiple
lineages of definitive blood cells, such as functional erythrocytes
and neutrophils. Hematopoietic cells arise via an orderly
developmental pathway that includes PS cells, mesoderm, and
primitive hematopoiesis.
Materials and Methods
Maintenance of human ES/iPS cells in serum-free
condition
Experiments were carried out with the human ES cell lines
KhES-1 and KhES-3 (kindly provided by Norio Nakatsuji) and
iPS cell lines 201B7 and 253G4 (kindly provided by Shinya
Yamanaka). Stable derivatives of ES cells carrying the transgene
for green fluorescent protein (GFP) after CAG promoter were also
used [38,39]. The ES/iPS cells were maintained on a tissue culture
dish (#353004; Becton-Dickinson, Franklin Lakes, NJ) coated
with growth factor-reduced Matrigel (#354230; Becton-Dick-
inson) in mTeSR1 serum-free medium (#05850; STEMCELL
Technologies, Vancouver, BC, Canada). The medium was
replaced everyday. Passage was performed according to the
manufacturer’s protocol.
Differentiation of ES/iPS cells
First, undifferentiated ES/iPS cell colonies were prepared at the
density of less than 5 colonies per well of a 6-well tissue culture
plate (#353046; Becton-Dickinson). When individual colony grew
up to approximately 500 mm in diameter, mTeSR1 maintenance
medium was replaced by Stemline II serum-free medium
(#S0192; Sigma-Aldrich, St. Louis, MO) supplemented with
Insulin-Transferrin-Selenium-X Supplement (ITS) (#51500-056;
Invitrogen, Carlsbad, CA). This day was defined as day 0 of
differentiation. BMP4 (#314-BP-010; R&D Systems, Minneapo-
lis, MN) was added for first 4 days and replaced by VEGF165
(#293-VE-050; R&D Systems) and SCF (#255-SC-050; R&D
Systems) on day 4. On day 6, the cytokines were again replaced by
the haematopoietic cocktail described in the result section.
Concentration of each cytokine was as follows: 20 ng/mL
BMP4, 40 ng/mL VEGF165, 50 ng/mL SCF, 10 ng/mL TPO
(#288-TPN-025; R&D Systems), 50 ng/mL IL3 (#203-IL-050;
R&D Systems), 50 ng/mL Flt-3 ligand (#308-FK-025; R&D
Systems), 50 ng/mL G-CSF (#214-CS-025; R&D Systems),
50 ng/mL complex of IL-6 and soluble IL-6 receptor (FP6)
(kindly provided by Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan)
and 5 IU/mL EPO (#329871; EMD Biosciences, San Diego,
CA). Thereafter, the medium was changed every 5 days.
Antibodies
The primary murine anti-human monoclonal antibodies used
for flow cytometric (FCM) analysis are as follows: PE-conjugated
anti-SSEA-4 (#330405; BioLegend, San Diego, CA), Alexa
FluorH 647-conjugated anti-TRA-1-60 (#560122; Becton-Dick-
inson), biotin-conjugated anti-CD140a (#323503; Biolegend),
Alexa FluorH 647-conjugated anti-KDR (#338909; BioLegend),
PE-conjugated anti-CXCR4 (#555974; Becton-Dickinson), PE-
conjugated anti-CD117 (#313203; BioLegend), PE-conjugated
CD34 (#A07776; Beckman Coulter, Brea, CA), FITC-conjugated
CD43 (#560978; Becton-Dickinson), and APC-conjugated CD45
(#IM2473; Beckman Coulter). A streptavidin-PE (#554061;
Becton Dickinson) was used as secondary antibody against
biotin-conjugated primary antibody. The primary antibodies used
to immunostain the colonies and floating blood cells included anti-
human Oct3/4 (#611203; Becton-Dickinson), T (#sc-101164;
Santa Cruz Biotechnology, Santa Cruz, CA), KDR (#MAB3571;
R&D Systems), VE-Cadherin (#AF938; R&D Systems), and
rabbit anti-pan-human Hb (#0855129; MP Biomedicals, Solon,
OH). FITC-conjugated donkey anti-rat antibodies and Cy3-
conjugated goat anti-mouse antibodies (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA) were used as secondary
antibodies.
Cytostaining
Floating cells were centrifuged onto glass slides by using a
Shandon Cytospin 4 Cytocentrifuge (Thermo, Pittsburgh, PA) and
analysed by microscopy after staining with May–Giemsa or
myeloperoxidase. For immunofluorescence staining, cells fixed
with 4% paraformaldehyde were first permeabilized with
phosphate-buffered saline containing 5% skimmed milk (Becton–
Dickinson) and 0.1% Triton X-100 and then incubated with
primary antibodies, followed by incubation with FITC or Cy3-
conjugated secondary antibodies. Nuclei were counterstained with
4,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich).
Flow cytometric analysis
The adherent cells were treated with Dispase (#354235;
Becton-Dickinson) and harvested by gently scraping the culture
dish. Aggregated cell structure was chopped by a pair of scissors,
processed by GentleMACS (Milteny Biotec, Germany) and then
dispersed by 40-mm strainers (#2340; Becton-Dickinson) before
staining with antibodies. Dead cells were excluded by DAPI
staining. Samples were analysed using a MACSQuant (Milteny
Biotec) and FlowJo software (Thermo). Cell sorting was performed
using a FACSVantage or FACSAria (Becton–Dickinson).
RNA extraction and real-time quantitative PCR analysis
RNA samples were prepared using silica gel membrane-based
spin-columns (RNeasy Mini-KitTM; Qiagen, Valencia, CA) and
subjected to reverse transcription (RT) with a Sensiscript-RT Kit
(Qiagen). All procedures were performed according to the
manufacturer’s instructions. For real-time quantitative PCR,
primers and the fluorogenic probes were designed and selected
according to Roche Universal Primer library software (Roche
Diagnostics) and MGB probe system (Applied Biosystems,
Carlsbad, CA). The instrument used was the Applied Biosystems
ABIPrism 7900HT sequence detection system, and the software
for data collection and analysis was SDS2.3. A GAPDH RNA
probe (Hs00266705_g1) was used to normalise the data.
Clonogenic colony-forming assay
At the indicated days of culture, from days 6 through 25, the
adherent cells were treated with dispase and harvested. They were
incubated in a new tissue-culture dish (#3003, Becton–Dickinson)
for 10 min to eliminate adherent non-haematopoietic cells [40].
Floating cells were collected and dispersed by 40-mm strainers. After
dead cells were eliminated by labeling with Dead-Cert Nanopar-
ticles (#DC-001, ImmunoSolv, Edinburgh, UK), live hematopoi-
etic cells were cultured at a concentration of 1610
3 (for counting
CFU-G) or 10
4 (for counting CFU-Mix, BFU-E, and CFU-GM)
cells/ml in 35-mm petri dishes (#1008; Becton-Dickinson) using
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CELL Technologies) as previously described. Colonies were
counted after 14–21 days of incubation, and colony types were
determined accordingtothecriteria described previously[41,42,43]
by in situ observation using an inverted microscope. The
abbreviations used for the clonogenic progenitor cells are as follows:
CFU-Mix, mixed colony-forming units; BFU-E, erythroid burst-
forming units; CFU-GM, granulocyte–macrophage colony-forming
units; and CFU-G, granulocyte colony-forming units.
Single-cell deposition assay
The single-cell deposition assay was performed as describ-
ed previously [17,18,28][17,18,28][17,18,28][17,18,28][17,18,28]
[17,18,28][17,18,28][17,18,28][17,18,28][17,18,28][17,18,28][17,18,28]
[17,18,28][17,18,28][17,18,28][17,18,28][17,18,28][17,18,28]
[17,18,28][17,18,28]. In brief, single sorted cells were deposited
in individual wells of 96-well plates with confluent OP9 layers
and cultured for 14 days. Wells were scored by morphological
observation for hematopoietic colony detection and stained
with anti-vascular endothelial cadherin (VE-cadherin) antibod-
ies for endothelial lineage detection.
Chemotaxis assay
Chemotaxisassaywas performedwith modified Boydenchamber
method using 3.0-mm pore size cell culture inserts (Becton
Dickinson). In brief, 5610
4 cells harvested from floating cell
fraction at day 25 were added to the upper chamber and induced to
migrate towards the lower chamber containing 10 nM formyl-Met-
Leu-Phe (fMLP; Sigma-Aldrich) for 4 hours at 37uC. After
incubation, the cells in the lower chamber were collected and
counted using a MACSQuant flow cytometer (Miltenyi Biotec). For
quantitative analysis, equivalent amount of 6-mm beads (Becton
Dickinson) were added to each FCM sample, and the cell numbers
were determined by measuring the ratio of cells to beads.
Phagocytosis and detection of reactive oxygen species
Phagocytosis and production of reactive oxygen species were
detected by chemiluminescent microspheres (luminol-binding
carboxyl hydrophilic microspheres; TORAY, Tokyo, Japan) as
described previously [44]. In brief, 2610
4 floating cells were
suspended in 50 mL of the reaction buffer (HBSS containing
20 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid
(HEPES)) per tube. To activate the system, 5 ml chemiluminescent
microspheres were added, and light emission was recorded
continuously using a luminometer (TD-20/20; Turner Designs,
Sunnyvale, CA). During the measurement, samples were kept at
37uC. To inhibit the reaction, 1.75 mg of cytochalasin B (Sigma-
Aldrich) was added to the samples.
Measurement of oxygen-binding ability
Floating blood cells derived from KhES-1 and 253G4 strains
were harvested on day 32 of differentiation (with erythropoietic
cytokine cocktail). Oxygen dissociation curves for hemoglobin
were measured using a Hemox-Analyzer (TCS Scientific Corpo-
ration, New Hope, PA) as previously reported [45,46].
Results
Stepwise generation of functional hematopoietic cells
from human ES/iPS cells in the serum-free monolayer
culture without animal-derived stromal cells
To assess the differentiation activity of each human ES/iPS cell
line with high reproducibility, we used a chemically defined
medium in the monolayer differentiation culture and succeeded in
inducing various blood cells, including erythrocytes and neutro-
phils (Figure 1a). To present the developmental process from
human ES/iPS cells to blood cells in an orderly manner, we
divided the entire process into 3 steps: (1) initial differentiation into
PS cells, (2) induction of the hematopoietic mesoderm (Movie S1),
and (3) commitment to the hematopoietic lineages (Movie S2).
Step 1: Induction of PS-like cells from undifferentiated
human ES/iPS cells with BMP4 (days 0–4). First, we
examined the efficacy of initial progression from undifferentiated
pluripotent cells (KhES-1) into PS-like cells according to the
expression of representative marker genes, such as T and Mixl1
(Figure 1b), and the change in morphology (Figure 1c). Without
cytokines, these genes were only slightly upregulated during the
first 4 days. However, when 40 ng/mL BMP4 was added to the
culture, the expression levels of these genes increased, which is
compatible with previous reports on the importance of BMP4 in
mesodermal/endodermal differentiation via PS during early
embryogenesis (Figure 1b). Further, transcription levels of the
undifferentiated marker Nanog decreased. During this period, the
colonies showed substantial morphological changes at the margins,
and cell density decreased and cell contact diminished (Movie S1,
Figure 1c). Immunohistochemical staining assays confirmed the
upregulation of T and the lateral mesodermal marker, KDR, and
downregulation of Oct3/4 (Figure 1c). However, regarding
ectodermal commitment, the representative marker gene Sox1
was hardly detected on day 4 in the presence of BMP4 (Figure 1b).
To assess the role of BMP4 in this step, we analyzed the
differentiation efficacy of individual ES (KhES-1 and KhES-3) and
iPS (201B7 and 253G4) cell strains with various concentrations of
BMP4 in the presence or absence of its inhibitor, Noggin. As
shown in Figure 1d, T gene expression was upregulated by BMP4
dose-dependently up to 20 ng/mL and was almost completely
suppressed by the BMP4 inhibitor, Noggin, in both ES and iPS
cells. This suggested that BMP4 was critical at this stage. From
these results, we used BMP4 at 20 ng/mL concentration in
subsequent experiments.
We also assayed the expression of several cell surface protein
markers in this step (Figure 1e). On day 4, undifferentiated cell
markers (TRA-1-60 and SSEA4) were downregulated, whereas
paraxial and lateral mesoderm cell markers (CD140a and KDR)
and markers for mesodermal and hematopoietic progenitors
(CXCR4 and CD117) were upregulated. The early-phase
hematopoietic-committed cell markers (CD34 and CD43) were
still negative at this stage. Similar results were obtained for both
ES and iPS cells (data not shown), suggesting that our system
initiated paraxial and lateral mesodermal differentiation from
pluripotent stem cells during Step 1 [33].
Step 2: Generation of KDR
+CD34
+CD45
2 progenitors
with VEGF and SCF (days 4–6). Our previous studies of
primate ES cells demonstrated that KDR
+CD34
+CD45
2
mesodermal progenitors derived in a VEGF-containing culture
on OP9 stromal cells included hematopoietic progenitors [17,18].
Therefore, we used this data to induce these progenitors in our
culture system. Considering the partial expression of KDR and
CD117 during the first step, we replaced BMP4 with 40 ng/mL
VEGF165 (ligand for KDR) and 50 ng/mL SCF (ligand for
CD117) on day 4 to accelerate selective differentiation to the
lateral mesoderm with hematopoietic activities (Figure 1a).
During the next 2 days, the colonies exhibited 2 distinct regions:
a plateau-like central area with stratified components and a
surrounding area with monolayer cells (Movie S1, Figure 1c). On
day 6, the mRNA expression pattern indicated the dominance of
mesodermal cells rather than endodermal or ectodermal lineages
ES/iPS-Derived Hematopoiesis in Defined Culture
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emergence of new cell fractions that were positive for KDR,
CD117, CXCR4, and CD34 but negative for CD140a, CD43,
and CD45 (Figure 2b). Our system robustly supports mesodermal
induction from both ES and iPS cells, despite differences in
efficacy among cell strains (Figure 2c).
Further, immunohistochemical staining for KDR indicated an
uneven distribution of KDR
+ cells at the marginal zone of the
plateau area (Figure 1c), suggesting that differentiation polarity
within the colonies resulted in site-specific emergence of putative
hematopoietic mesodermal progenitors.
Step 3: Production of functional blood cells dependent on
cytokine cocktails (day 6 onward). On day 6, we changed the
culture medium to another chemically defined medium containing
hematopoietic cytokines (Figure 1a). To achieve lineage-directed
differentiation, we used 2 combinations of cytokines: a myeloid-
Figure 1. Blood cell induction from pluripotent stem cells starts with commitment into primitive streak. a. A schema of stepwise
haematopoietic differentiation of human ES/iPS cells. b. Gene expression analysis of colonies at the beginning of differentiation (day 0) and the end
of step 1 (day 4) with/without 40 ng/mL BMP4. Data from KhES-1 are shown as representative. c. Phase contrast microscopies and
immunofluorescence staining of colonies during initial differentiation. Data from KhES-1 are shown as representative. d. Relative expression of T
at day 4 of differentiation with different combinations of BMP4 and its inhibitor Noggin. Where shown, bars represent standard deviation of the mean
of three independent experiments; Scale bars, 500 mm. Data from KhES-1 and 253G4 strains are shown as representative. e. Flow cytometric analysis
of differentiating cells on day 4, indicating the down-regulation of immature cell markers and up-regulation of differentiated progenitor markers.
Data from KhES-1 are shown as representative.
doi:10.1371/journal.pone.0022261.g001
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G-CSF; and an erythropoietic-differentiation cocktail containing
SCF, TPO, IL3, FP6, and EPO.
Regardless of the cocktails, the colonies first exhibited a rosary-
like appearance, with small sac-like structures aligned along the
margins of the plateau areas, and grew for several days (Figure 3a,
left panel). Hematopoietic cell clusters emerged from the edge of
these structures on days 10–12, followed by the appearance of
floating blood cells a few days later, which increased thereafter;
hematopoietic clusters grew in size and number, and some
exhibited areas with a cobblestone-like appearance (Figure 3a,
right 3 panels; Movie S2). When fresh medium with the cytokines
was supplied every 5 days, blood cell production was observed in
both ES and iPS cell experiments until day 50 of differentiation,
whereas few hematopoietic cells appeared without the cytokines
(data not shown).
As expected, the myeloid-induction cocktail induced myelo-
monocytic lineages predominantly positive for CD45. Blood cells
harvested on day 30 exhibited morphology compatible with
myelomonocytic precursors and mature neutrophils, and displayed
positive myeloperoxidase staining (Figure 3b). On the other hand,
the erythropoietic-differentiation cocktail yielded cell lineages that
included hemoglobin-positive (Hb
+) erythroid cells and CD41
+
megakaryocytes (Figure 3b). In the KhES-1 strain (3.5 [standard
deviation (SD)=1.5] undifferentiated colonies 250 mmm in
diameter were initially plated in individual wells of 6-well plates
Figure 2. Characterization of cells during initial differentiation with lineage-specific marker expression. a. Expression analysis of
lineage-specific marker genes at the beginning of differentiation (day 0) and the end of step 2 (day 6). Bars represent standard deviation of the mean
of three independent experiments. Data from KhES-1 are shown as representative. b. The development of progenitors on day 6 positive for lateral
mesoderm markers but negative for paraxial mesoderm and haematopoietic cell markers. Leftmost column shows the gating strategy for eliminating
dead cells and debris. Data from KhES-1 are shown as representative. c. Efficacy of inducing KDR
+CD34
+ or 2 mesodermal progenitors from each two
lines of human ES cells and iPS cells. Bars represent standard deviation of the mean of three independent experiments.
doi:10.1371/journal.pone.0022261.g002
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harvested blood cells on day 30 revealed the existence of 7.7610
5
(SD=2.3610
5) different cell lineages per well, including 36.0%
(SD=6.4%) CD235a
+ erythroid and 53.2% (SD=9.4%) CD45
+
myelomonocytic lineages, but no lymphoid lineage cells (Figure 3c).
Although the differentiation efficacy and lineage distribution
depend not only on the cytokines but also on the cell strains, the
data indicates that human ES and iPS cells develop into various
lineages of hematopoietic cells, robustly and orderly, in our novel
monolayer culture system without xeno-derived serum or stromal
cells (Figure 3d).
ES/iPS cell-derived hematopoietic cells have similar
potential to in vivo-derived blood cells in function
Considering the use of ES/iPS cell-derived hematopoiesis for
various clinical and research applications, it is important to
confirm the function of the generated blood cells. Neutrophils
derived with the myeloid-induction cocktail exhibited migration
activity in response to the chemoattractant fMLP (Figure 4a) and
phagosome-dependent reactive oxygen production, which was
inhibited by the phagosome destruction agent, cytochalasin B
(Figure 4b). On the other hand, erythroid lineage cells derived
with the erythropoietic-differentiation cocktail (harvested on day
32 of differentiation) exhibited an oxygen dissociation curve that
was similar, despite being slightly left-shifted, to those obtained
with adult and cord blood cells (Figure 4c). These data indicate
that our culture facilitates robust and orderly development of
human ES and iPS cells into functional hematopoietic cells with
similar potential to in vivo-derived blood cells.
Clonogenic hematopoietic development from human
ES/iPS cell-derived progenitors
The human hematopoietic system is a hierarchy of various
component cells from stem or progenitor cells to terminally
differentiated cells. For example, CD34
+ cells in umbilical cord
blood or bone marrow contain putative hematopoietic stem cells
and are used as a source of stem cell transplantation. The
identification and proliferation of such cells in vitro have been of
great interest in medical science research.
To assess the potential of our system for supporting generated
immature stem or progenitor cells, we evaluated the colony-
forming ability of the cultivated hematopoietic progenitors in the
system. Accordingly, the cells were cultured with SCF, TPO, IL3,
FLT-3 ligand, and FP6. In these conditions, CD34
+CD45
+
hematopoietic cells existed up to day 25, indicating that the
immature hematopoietic cells can be maintained in our serum-free
culture (Figure 5a).
We harvested adherent blood cells from the previously
described culture and transferred them into a methylcellulose-
containing medium to perform colony-forming assays with SCF,
TPO, IL3, G-CSF, and EPO. As shown in Figure 5b and c, CFU-
Mix, BFU-E, CFU-GM, and CFU-G colonies developed from
plated cells. The total number of colonies increased dramatically
from day 6 to day 10, then gradually increased until day 15 and
decreased thereafter. CFU-Mix and BFU-E colonies were mainly
observed until day 15 and were thereafter replaced by CFU-GM
and CFU-G colonies. Similar tendencies were observed in both ES
and iPS cells. These results suggest that our culture system can
incubate multipotent hematopoietic stem or progenitor cells over a
period of time.
Identification of KDR
+CD34
+CD45
2 bipotential
hemoangiogenic progenitors derived in serum-free
conditions
During embryogenesis, hematopoietic development is closely
associated with endothelial lineage commitment [47,48], and
Figure 3. Human ES/iPS cell-derived haematopoiesis in a
monolayer culture free from animal serum or stromal cells. a.
Sequential phase contrast pictures showing haematopoietic develop-
ment.Scale bars, 500 mm (left twopanels) and100 mm (right twopanels).
DatafromKhES-1 areshownas representative.b.Floatingcellsharvested
on day 30 showing various lineages of haematopoietic cells; MPO-
positive myeloid lineage cells (leftmost panels), pan-human Hb-positive
erythroid lineage cells (centre panels), and CD41-positive megakaryo-
cytes (rightmost panels). Scale bars, 100 mm.Datafrom KhES-1areshown
as representative. c. Expression of lineage-specific antigens on floating
cells harvested on day 30; Myeloid lineages (CD13 and CD45), erythroid
lineages (CD235a), T cells (CD3), and B cells (CD19). Data from KhES-1 are
shown as representative. d. Numbers and fraction of blood cells induced
from each two lines of human ES cells and iPS cells. Bars represent
standard deviation of the mean of three independent experiments.
doi:10.1371/journal.pone.0022261.g003
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into the common multipotent progenitors that differentiate into
both blood and endothelial cells at the single cell level on OP9
stroma [17,28,49]. Although the experiments described thus far
demonstrated that the serum-free, xeno-cell-free culture condition
supported human ES/iPS cell-derived hematopoiesis in an orderly
manner, as observed during embryogenesis, it was unclear which
day 6 fraction(s) developed into blood cells. To clarify this point,
human ES cells stably expressing green fluorescent protein (GFP)
were cultured, then 1610
4 cells of GFP
+KDR
2CD34
2CD45
2
(Fraction A), GFP
+KDR
+CD34
2CD45
2 (Fraction B), and
GFP
+KDR
+CD34
+CD45
2 (Fraction C) fractions were transferred
on day 6 into a synchronous differentiation culture of unlabeled
ES cells (Figure 6a). Nineteen days later (day 25 of differentiation),
GFP
+ small round cell-containing colonies were observed
predominantly in Fractions B and C, and FCM analysis of the
entire culture confirmed the emergence of GFP
+CD45
+ cells
mainly from Fraction C (Figure 6b). On the other hand, few blood
cells positive for GFP were generated from Fraction A. These
results were obtained with 2 independent strains of human ES cells
(KhES1-EGFPneo on KhES-1 and KhES3-EGFPneo on KhES-3)
(Figure 6c) and indicated that hematopoietic progenitors were
present in the KDR
+ fraction, particularly in the KDR
+CD34
+
fraction, on day 6 of differentiation.
Finally, we performed a single-cell deposition assay by
transferring single sorted human ES/iPS cell-derived
GFP
+KDR
+CD34
+CD45
2 cells, which were negative for VE-
cadherin, on day 6 into individual wells of 96-well plates coated
Figure 4. Functional blood cells derived from human ES/iPS cells. a. Number of migrated cells that permeated through the transwell
membrane with or without fMLP. Values were normalised to the number of counting beads, and the control values were arbitrarily set to the
condition without fMLP. Data from KhES-1 are shown as representative. b. Assay for phagocytosis-induced respiratory burst activity using
chemiluminescent microspheres (luminol-binding microspheres). Abbreviation: RLU, relative light units. Data from KhES-1 are shown as
representative. c. Oxygen dissociation curves of erythroid cells derived from human ES/iPS cells (harvested on day32 of differentiation), human
cord blood, and adult peripheral blood. Where shown, bars represent standard deviation of the mean of three independent experiments.
doi:10.1371/journal.pone.0022261.g004
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proportion of hematopoietic cell (HC) development, VE-cadherin
+
endothelial cell (EC) development, and HC plus EC development
on day 20 were 9.0%, 6.8%, and 4.0%, respectively, for KhES-1
and 11.6%, 12.7%, and 8.3%, respectively, for 253G4 iPS cells.
These results demonstrate that the common mesodermal progen-
itors that can differentiate into both blood and endothelial cells at
the single-cell level are induced in our culture condition.
Discussion
In this study, we demonstrated the orderly mesodermal and
hematopoietic differentiation of human ES and iPS cells in a novel
serum-free monolayer culture condition. Simple manipulation of
cytokine combinations facilitated robust, reproducible, and highly
directed stepwise commitment to specific lineages of functional
blood cells.
There are several reports on hematopoietic differentiation of
human ES/iPS cells, such as murine-derived OP9 stromal cell
coculture and feeder/serum-free EB formation systems
[20,22,23,24,30,31,32,50]. However, two-dimensional cultures
containing xeno-serum/cells often cause dependency on their lots,
while complicated three-dimensional structures inside EBs make it
difficult to assess and control conditions for inducing specific
progenitors. Actually, few in vitro systems have been able to
reliably reproduce hematopoietic development from mesodermal
progenitors or model the in vivo coexistence of developing
hematopoietic cells and their autologous microenvironments in
Figure 5. Hematopoietic stem/progenitor cells in culture. a. Sequential FCM analysis of cells harvested on indicated days showing the
existence of CD34
+CD45
+ haematopoietic progenitor cells in culture. Data from KhES-1 are shown as representative. b. Various colony types on MTC-
containing medium clonally emerged from single haematopoietic progenitor cells. Data from KhES-1 are shown as representative. c. Numbers of
each colony type derived from different days of culture. Bars represent standard deviation of the mean of three independent experiments. Data from
KhES-1 and 253G4 strains are shown as representative.
doi:10.1371/journal.pone.0022261.g005
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monolayer culture facilitates observation of the stepwise develop-
ment of pluripotent cells to blood cells via common hemoangio-
genic progenitors and the behavior of hematopoietic cells on
autologous stromal cells. Consequently, assays for elucidating
differences in lineage specification of various ES/iPS cell strains,
including hematopoietic potential, can be performed with high
reproducibility. This is particularly important because individual
pluripotent cell strains vary in differentiation potentials [51,52,53].
This study demonstrated quantitative differences in hematopoietic
differentiation efficacy and lineage commitment among 4 ES/iPS
cell strains.
Because human ES/iPS cells are feasible cell sources for various
clinical applications, scientific and medical communities have
shown continuing interest in hematopoietic stem cell induction
from ES/iPS cells. Previous trials have indicated that murine ES
cell-derived hematopoietic cells overexpressing HoxB4 [54] can
replenish the bone marrow of lethally irradiated recipient mice.
However, it remains a challenge to develop bona fide human
hematopoietic stem cells with bone marrow reconstitution activity
at the single-cell level. In our study, we observed many cobblestone
area-forming cells, which reportedly indicate the existence of very
immature hematopoietic progenitors. Moreover, FCM analyses
and colony-forming assays suggested that ES and iPS human cell-
Figure 6. Haematopoietic differentiation from KDR
+CD34
+ mesodermal progenitors. a. Schema of the protocol for measuring
haematopoietic activities of depicted fractions on day 6. b. Each sorted fraction-derived haematopoiesis on day 25 detected by fluorescent
microscopy and FCM analysis. Data from KhES-1 are shown as representative. c. Ratio of CD45
+ cells in GFP
+ fraction on day 25 showing the strongest
haematopoietic activity of fraction C followed by fraction B. d. Single KDR
+CD34
+CD45
2 cell-derived haematopoietic colonies (HC), VE-cadherin
+
endothelial colonies (EC), and HC+EC colonies generated on OP9 cell layers. Data from KhES-1 are shown as representative. e. Number of wells that
showed HC, EC, and EC+HC development.
doi:10.1371/journal.pone.0022261.g006
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hematopoietic stem/progenitor cells. We are in the process of
determining in vivo repopulating ability of cells harvested from our
culture by using serial transplantation into immunodeficient mice
to assess the possibility of inducing feasible cell sources for various
clinical applications, such as cell therapies and disease investiga-
tion.
Finally, time-lapse imaging strongly indicated crosstalk between
hematopoietic cells and the autologous microenvironment com-
posed of non-hematopoietic cells. Emerged blood cells move about
actively and generate colonies in surrounding cell layers,
suggesting the importance of a direct interaction between blood
cells and microenvironmental cells for the maintenance, prolifer-
ation, and differentiation of stem or progenitor cells (Movie S3). In
fact, a model of hematopoietic disorders triggered by mutation in
the bone marrow microenvironment has been recently reported
[55]. However, further investigation is necessary to identify the
mechanisms responsible for such phenomena. Our culture may
aid these investigations as it facilitates simple and sequential
harvest of hematopoietic cells with minimal contamination by
autologous adherent cell layers.
In conclusion, this study presents novel methods for analyzing
the mechanisms of normal hematopoiesis in a robust, reproduc-
ible, and stepwise manner. Furthermore, employing gene-
manipulated ES cells or disease-specific iPS cells will supply in
vitro models of disease pathology, thereby providing further
insights into hematological defects in conditions such as aplastic
anemia and myelodysplastic syndromes.
Supporting Information
Movie S1 Time-lapse microscopic movie showing the
morphological change in a single colony from day 0 to
day 6 (initial differentiation). In this period, a colony begins
forming a rosary-like morphology as it differentiates. The pictures
were automatically taken every 8 minute by Biostation IM (Nikon
Instruments, Tokyo, Japan).
(MOV)
Movie S2 Time-lapse microscopic movie showing the
morphological change in a single colony from day 6 to
day 25 (hematopoietic differentiation). After adding
hematopoietic cytokines on day 6, hematopoietic cells first emerge
from the areas near the edge of stratified zone. The pictures were
automatically taken every 8 minute by Biostation IM (Nikon
Instruments, Tokyo, Japan).
(MOV)
Movie S3 Close-up time-lapse microscopic movie show-
ing hematopoietic cells moving about and generating
colonies in surrounding cell layers. The pictures were
automatically taken every 8 minute by Biostation IM (Nikon
Instruments, Tokyo, Japan).
(MOV)
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